Carl A. Riddick, MD, FCCP

503-297-3778
Areas of Focus: 
Critical Care Medicine
Acute Respiratory Failure
Asthma
Pleural Disease
Interstitial Lung Disease

About Me

Dr. Carl Riddick earned his medical degree at the Johns Hopkins University School of Medicine. He completed his Internship in General Surgery at the US Naval Medical Center San Diego, his residency in Internal Medicine at University of California Los Angeles and his Pulmonary and Critical Care fellowship at University of California San Diego. He is Board Certified in Pulmonary Disease and in Critical Care Medicine. He has been the Medical Director of the Intensive Care Unit at Providence St. Vincent Medical Center since 2004.

He is also the Medical Director for Subspecialty Education in Critical Care Medicine at Providence St. Vincent Medical Center Internal Medicine Program, and is the Regional Co-Medical Director of Pulmonary and Critical Care Services for Providence Health & Services in Oregon. Dr. Riddick has assisted in the development of protocols designed to ensure up to date, standardized care in intensive care units across Oregon. Along with his passion for critical care, areas of interest include venous thromboembolic disease, interstitial lung disease, and pleural disease.

My Work

Hospitals Served: 
Providence St. Vincent Medical Center
Areas of Focus: 
Critical Care Medicine
Acute Respiratory Failure
Asthma
Pleural Disease
Interstitial Lung Disease

Education & Honors

Board Certified: 
Pulmonary & Critical Care Medicine
Education & Training: 
  • Post Doctoral Research Fellowship, University of California, San Diego, San Diego, CA, 1997
  • Fellowship, Pulmonary and Critical Care Medicine, University of California, San Diego, San Diego, CA, 1994
  • Internship and Residency, Internal Medicine, University of California, Los Angeles, Los Angeles, CA, 1991
  • Internship, General Surgery, United States Navy Naval Hospital, San Diego, CA, 1985
  • MD, Johns Hopkins University School of Medicine, Baltimore, MD, 1984
  • BA, Economics, Yale University, New Haven, CT, 1980
Leadership: 
  • Medical Director, Intensive Care Unit, Providence St. Vincent Medical Center
  • Medical Director, Subspecialty Education in Critical Care Medicine, Providence St. Vincent Medical Center Internal Medicine Program
  • Regional Co-Medical Director, Critical Care Services, Providence Health & Services in Oregon
Honors: 
  • Outstanding Teacher Award-Specialist, Providence St. Vincent Residency Training Program, 1998-1999, 2004-2005, 2006-2007
  • Faculty Development Program Fellowship Award, Robert Wood Johnson foundation, 1994-1997
  • Postdoctoral Fellow Award for Excellence in Research, American Federation of Clinical Research, Western Society Meeting, Carmel, CA, 1995
Publications: 
  • Riddick CA. Pleural Empyema. In: Manual of Clinical Problems in Pulmonary Medicine, editors: Bordow RA. Ries AI., Morris TA. 6th Edition: Lippincott, Williams and Wilkins, 2005.
  • Ring WL, Riddick CA, Baker JR, et al. Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein via granulocyte macrophage colony-stimulating factor and interleukin-3. J Clin Invest, Vol 97, No. 5, March 1996. 1293-1301
  • Ring WL, Riddick CA, Baker JR, et al. Human monocytes lose 5-lipoxygenase and FLAP as they differentiate into monocyte-derived macrophages in vitro. American J of Physiol, Cell Physiol, Vol 271, July 1996, C372-C377
  • Serio KJ, Baker JR. Ring WL, el at (#4). Leukotriene B costimulates 5-lipoxygenase activity in neutrophils via increased 5-lipoxygenase translocation. American J of Physiol, Cell Physiol. Vol 272, Apr 1997, C1329-C1334
  • Riddick CA, Ring WL, Baker JR, et al. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in mononuclear phagocyres and THP-J cells. European J of Biochem, Vol. 246. No. 1. May 1997, 112-118
  • Ring WL, Riddick CA, Baker JR, el al. Activated lymphocytes increase expression of 5-lipoxygenase and its activating protein in THP-1 cells. American J of Physiol. Cell Physiol, Vol 273, Dec 1997, C2057-64
  • Riddick CA, Regan MR, Hodulik CR, et al. TGF-B2 increases expression of LTC4 synthase in inflammatory cells via increased transcription. J of Immunol, Vol 162, No. 2. Jan 1999, 1101-7
  • Riddick CA, Schneiderman LJ. Distinguishing Between Effect and Benefit. J Clin Ethics, 5(1),4 T-43, Spring 1994.
Other Activities: 
  • Member, American Thoracic Society
  • Fellow, American College of Chest Physicians
  • Member, Society of Critical Care Medicine
  • Clinical Instructor in Medicine, University of California San Diego, 1993-1997